Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Chen-Guo Chen"'
Autor:
Ping Chen, Han-Peng Huang, Yi Wang, Jun Jin, Wei-Guo Long, Kan Chen, Xiao-Hui Zhao, Chen-Guo Chen, Jian Li
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-17 (2019)
Abstract Background Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are being wildly used as target therapy in non-small-cell lung cancer (NSCLC). However, NSCLC patients with wild-type EGFR and KRAS mutation are primary res
Externí odkaz:
https://doaj.org/article/fe6848e03c674fe7b583c283c387e6c7
Autor:
Yi Wang, Chen-Guo Chen, Xiao-Qin Li, Wei-Guo Long, Jin-Yu Su, Jing Ren, Yu-Min Zhu, Qian Jiang, Jian Li
Publikováno v:
Cellular Oncology. 44:135-150
Paclitaxel is an anticancer drug for the treatment of non-small cell lung cancer (NSCLC). However, drug-resistance remains a major problem. Honokiol is a natural component which has been found to exhibit anti-tumor activity. Paclitaxel and honokiol h
Autor:
Mei-Yu Li, Chen-Guo Chen, Shui Wang, Zhen-Nan Li, Jian Li, Yang Shu, Xiao-Qin Li, Xiaohui Zhao
Publikováno v:
Biochemical and biophysical research communications. 528(3)
Tamoxifen resistance is a major roadblock in the treatment of patients with breast cancer. Ribonucleotide reductase M2 (RRM2) was found to be involved in acquired resistance of breast cancer cells (BCCs) to tamoxifen. Here, we used GW8510, which has
Autor:
Chen-Guo Chen, Jun Jin, Yi Wang, Wei-Guo Long, Kan Chen, Xiaohui Zhao, Han-Peng Huang, Ping Chen, Jian Li
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-17 (2019)
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-17 (2019)
Background Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are being wildly used as target therapy in non-small-cell lung cancer (NSCLC). However, NSCLC patients with wild-type EGFR and KRAS mutation are primary resistant to
Autor:
Chen, Ping, Huang, Han-Peng, Wang, Yi, Jin, Jun, Long, Wei-Guo, Chen, Kan, Zhao, Xiao-Hui, Chen-Guo Chen, Li, Jian
Figure S1. (a) H157, (b) H1299 and (c) PC9 cells were treated with indicated drug combination. The combination index (CI) values for the drugs were calculated according to the Chou-Talalay’s method. (d) The knockdowns of Sp1, Sp3, Beclin-1 and ATG7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb8276ec9b04a9bedb0590b4353d5e4e
Autor:
Chen, Ping, Huang, Han-Peng, Wang, Yi, Jin, Jun, Long, Wei-Guo, Chen, Kan, Zhao, Xiao-Hui, Chen-Guo Chen, Li, Jian
Table S1. List of primer sequences used in this study. (PDF 67 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e44aa357d575c0b72b4b97ef1c78f24
Autor:
Zhen-Nan Li, Yang Shu, Chen-Guo Chen, Yi Wang, Xiao-Qin Li, Xiao-Hui Zhao, Mei-Yu Li, Jing Ren, Jian Li
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Bangladesh Journal of Botany. 44:155-157
The comparison of fatty acid content in Camellia oleifera (L.) Kuntze oil and olive oil was done by GC. C. oleifera oil contained more C18:1n9c, C18:2n6c, C20:1 and C22:1n9 than olive oil. Olive oil did not contain C21:0 and C24:1 but more C8:0, C16:
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.